Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 01 04:00PM ET
89.22
Dollar change
+0.73
Percentage change
0.82
%
IndexRUT P/E- EPS (ttm)-2.78 Insider Own41.75% Shs Outstand58.63M Perf Week-1.63%
Market Cap6.28B Forward P/E- EPS next Y-4.18 Insider Trans-7.20% Shs Float40.66M Perf Month-13.80%
Income-173.59M PEG- EPS next Q-0.93 Inst Own60.05% Short Float12.78% Perf Quarter24.37%
Sales0.00M P/S- EPS this Y-61.03% Inst Trans0.66% Short Ratio10.38 Perf Half Y26.82%
Book/sh9.84 P/B9.06 EPS next Y-19.57% ROA-31.08% Short Interest5.20M Perf Year66.21%
Cash/sh9.35 P/C9.54 EPS next 5Y- ROE-32.81% 52W Range51.59 - 113.51 Perf YTD21.24%
Dividend Est.- P/FCF- EPS past 5Y-72.54% ROI-27.25% 52W High-21.40% Beta1.33
Dividend TTM- Quick Ratio17.44 Sales past 5Y0.00% Gross Margin- 52W Low72.94% ATR (14)3.84
Dividend Ex-Date- Current Ratio17.44 EPS Y/Y TTM-50.43% Oper. Margin0.00% RSI (14)37.04 Volatility3.36% 3.41%
Employees92 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.31 Target Price112.42
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-72.98% Payout- Rel Volume1.51 Prev Close88.49
Sales Surprise- EPS Surprise-15.32% Sales Q/Q- EarningsAug 08 BMO Avg Volume500.86K Price89.22
SMA20-9.08% SMA50-6.96% SMA20010.58% Trades Volume755,736 Change0.82%
Date Action Analyst Rating Change Price Target Change
Oct-24-24Initiated UBS Neutral $100
Aug-29-24Initiated Barclays Overweight $100
Apr-17-24Initiated Jefferies Buy $97
Apr-01-24Upgrade Leerink Partners Market Perform → Outperform $69 → $110
Feb-28-24Resumed Guggenheim Buy $99
Feb-23-24Initiated Robert W. Baird Outperform $105
Sep-27-23Initiated Stifel Buy $65
Aug-08-23Initiated SVB Securities Market Perform $42
Jul-24-23Initiated Guggenheim Buy $56
Jan-18-23Initiated Wedbush Outperform $39
Sep-18-24 04:05PM
Sep-16-24 10:23PM
04:04PM
11:18AM
07:00AM
07:57PM Loading…
Sep-14-24 07:57PM
05:29PM
05:00AM
Sep-13-24 09:53AM
Sep-09-24 06:30AM
Aug-29-24 06:30AM
Aug-08-24 06:30AM
Jul-23-24 04:52AM
Jul-22-24 06:30AM
Jul-16-24 06:30AM
06:30AM Loading…
Jul-11-24 06:30AM
Jun-24-24 06:00AM
May-29-24 06:30AM
May-17-24 04:48PM
06:31AM
May-16-24 04:23PM
04:01PM
May-09-24 01:56PM
09:27AM
07:19AM
06:30AM
May-08-24 05:22PM
10:21AM
May-01-24 05:05PM
Apr-08-24 04:30PM
07:00PM Loading…
Apr-05-24 07:00PM
06:30PM
Mar-29-24 07:01PM
Mar-25-24 07:01PM
Mar-19-24 07:01PM
Mar-05-24 04:52PM
Feb-29-24 04:32AM
Feb-27-24 06:30AM
06:15AM
Feb-22-24 04:00AM
Feb-12-24 06:30AM
Feb-01-24 06:30AM
Jan-08-24 06:30AM
Dec-22-23 03:01PM
Dec-21-23 01:01PM
06:30AM
Nov-14-23 07:15PM
06:30AM
Nov-04-23 07:02AM
Nov-01-23 06:30AM
Oct-23-23 02:50AM
Oct-17-23 06:27PM
Oct-16-23 09:55PM
07:30AM
Oct-13-23 06:30AM
Oct-07-23 01:00AM
Oct-05-23 07:13PM
10:29AM
01:01AM
Oct-04-23 04:13PM
12:21PM
Sep-18-23 06:30AM
Sep-05-23 06:30AM
Aug-31-23 06:30AM
Aug-17-23 06:40AM
Aug-10-23 06:30AM
Aug-08-23 10:02AM
Aug-01-23 06:30AM
Jul-21-23 08:50AM
Jun-07-23 08:50AM
May-24-23 06:30AM
May-11-23 06:30AM
Apr-19-23 06:30AM
Apr-18-23 09:00AM
Apr-02-23 10:56AM
Mar-23-23 06:30AM
Mar-16-23 06:30AM
Mar-14-23 05:59PM
Mar-01-23 06:30AM
Jan-04-23 06:30AM
Jan-02-23 09:40AM
Dec-13-22 10:15AM
Dec-12-22 03:44PM
Dec-02-22 08:50AM
Nov-17-22 12:00PM
Nov-10-22 06:30AM
Nov-03-22 08:13PM
Oct-31-22 09:14PM
07:15AM
Oct-28-22 04:18PM
04:06PM
11:10AM
12:01AM
Oct-26-22 06:30AM
Oct-23-22 09:26AM
Oct-17-22 06:30AM
Oct-06-22 06:30AM
Sep-20-22 10:16AM
Sep-07-22 06:30AM
Sep-01-22 06:30AM
Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shair MatthewDirectorOct 28 '24Sale91.732,000183,468224,522Oct 30 04:46 PM
Flynn James EDirectorOct 22 '24Sale97.752,000,000195,500,0008,670,512Oct 24 04:08 PM
Deerfield Healthcare InnovatioStockholderOct 22 '24Proposed Sale101.161,000,000101,160,000Oct 22 04:46 PM
Deerfield Private Design Fund StockholderOct 22 '24Proposed Sale101.161,000,000101,160,000Oct 22 04:44 PM
Porter James RichardPresident and CEOOct 15 '24Option Exercise27.8527,000751,950215,113Oct 17 04:45 PM
Porter James RichardPresident and CEOOct 15 '24Sale102.2827,0002,761,631188,113Oct 17 04:45 PM
James Richard PorterOfficerOct 15 '24Proposed Sale102.3881,0008,292,780Oct 15 04:23 PM
Noci DarleneChief Development OfficerOct 01 '24Option Exercise18.935,00094,65038,300Oct 02 05:34 PM
Noci DarleneChief Development OfficerOct 01 '24Sale101.745,000508,71833,300Oct 02 05:34 PM
Balcom AlexandraChief Financial OfficerSep 30 '24Option Exercise27.8510,000278,50043,300Oct 02 05:33 PM
Balcom AlexandraChief Financial OfficerSep 30 '24Sale101.0610,0001,010,62033,300Oct 02 05:33 PM
Darlene NociOfficerOct 01 '24Proposed Sale101.1910,0001,011,900Oct 01 04:16 PM
Alexandra BalcomOfficerSep 30 '24Proposed Sale102.1230,0003,063,600Sep 30 04:12 PM
Shair MatthewDirectorSep 23 '24Sale102.752,000205,500226,522Sep 25 04:44 PM
Pelish Henry E.Chief Scientific OfficerSep 16 '24Sale98.9232,7953,244,14033,300Sep 18 04:53 PM
Miller Deborah AnnChief Legal OfficerSep 16 '24Option Exercise18.938,000151,44041,300Sep 18 04:50 PM
Miller Deborah AnnChief Legal OfficerSep 16 '24Sale96.478,000771,79833,300Sep 18 04:50 PM
Miller Deborah AnnChief Legal OfficerSep 09 '24Option Exercise6.893,00020,67036,300Sep 11 04:55 PM
Miller Deborah AnnChief Legal OfficerSep 09 '24Sale88.183,000264,54633,300Sep 11 04:55 PM
Noci DarleneChief Development OfficerSep 03 '24Option Exercise18.935,00094,65038,300Sep 04 07:52 PM
Noci DarleneChief Development OfficerSep 03 '24Sale84.435,000422,14633,300Sep 04 07:52 PM
Balcom AlexandraChief Financial OfficerAug 30 '24Option Exercise27.8510,000278,50043,300Sep 04 04:52 PM
Balcom AlexandraChief Financial OfficerAug 30 '24Sale84.2310,000842,34933,300Sep 04 04:52 PM
Shair MatthewDirectorAug 26 '24Sale84.462,000168,914228,522Aug 27 04:51 PM
Pelish Henry E.Chief Scientific OfficerAug 23 '24Sale85.0810,500893,34066,095Aug 27 04:49 PM
Miller Deborah AnnChief Legal OfficerAug 23 '24Option Exercise23.8011,000261,75044,300Aug 27 04:47 PM
Miller Deborah AnnChief Legal OfficerAug 23 '24Sale85.0411,000935,44033,300Aug 27 04:47 PM
Conley EmilyDirectorAug 23 '24Option Exercise13.793,33445,9765,841Aug 27 04:44 PM
Conley EmilyDirectorAug 23 '24Sale85.023,334283,4572,507Aug 27 04:44 PM
Henry PelishChief Scientific OfficerAug 23 '24Proposed Sale84.1343,2953,642,408Aug 23 04:07 PM
Miller Deborah AnnChief Legal OfficerAug 08 '24Option Exercise6.893,00020,67036,300Aug 09 04:48 PM
Miller Deborah AnnChief Legal OfficerAug 08 '24Sale68.783,000206,34833,300Aug 09 04:48 PM
Noci DarleneChief Development OfficerAug 01 '24Option Exercise18.935,00094,65038,300Aug 02 04:45 PM
Noci DarleneChief Development OfficerAug 01 '24Sale77.225,000386,12533,300Aug 02 04:45 PM
Balcom AlexandraChief Financial OfficerJul 31 '24Option Exercise27.8510,000278,50043,300Aug 02 04:43 PM
Balcom AlexandraChief Financial OfficerJul 31 '24Sale79.5110,000795,07433,300Aug 02 04:43 PM
Shair MatthewDirectorJul 29 '24Sale79.592,000159,176230,522Jul 31 04:46 PM
Matthew ShairDirectorJul 29 '24Proposed Sale81.688,000653,440Jul 29 04:09 PM
Conley EmilyDirectorJul 15 '24Option Exercise13.795,00068,9507,507Jul 16 04:47 PM
Conley EmilyDirectorJul 15 '24Sale80.725,000403,6212,507Jul 16 04:47 PM
Miller Deborah AnnChief Legal OfficerJul 12 '24Option Exercise27.856,000167,10039,300Jul 16 04:45 PM
Miller Deborah AnnChief Legal OfficerJul 12 '24Sale80.166,000480,96033,300Jul 16 04:45 PM
Miller Deborah AnnChief Legal OfficerJul 08 '24Option Exercise6.893,00020,67036,300Jul 10 04:45 PM
Miller Deborah AnnChief Legal OfficerJul 08 '24Sale73.233,000219,68733,300Jul 10 04:45 PM
Noci DarleneChief Development OfficerJul 01 '24Option Exercise18.935,00094,65038,300Jul 02 04:47 PM
Noci DarleneChief Development OfficerJul 01 '24Sale75.545,000377,69633,300Jul 02 04:47 PM
Balcom AlexandraChief Financial OfficerJun 28 '24Option Exercise27.8510,000278,50043,300Jul 02 04:44 PM
Balcom AlexandraChief Financial OfficerJun 28 '24Sale75.4310,000754,34133,300Jul 02 04:44 PM
Shair MatthewDirectorJun 24 '24Sale80.222,000160,438232,522Jun 26 04:54 PM
Conley EmilyDirectorJun 14 '24Option Exercise13.795,00068,9507,507Jun 18 04:15 PM
Conley EmilyDirectorJun 14 '24Sale77.565,000387,7762,507Jun 18 04:15 PM
Miller Deborah AnnChief Legal OfficerJun 06 '24Option Exercise14.418,000115,32041,300Jun 07 04:44 PM
Miller Deborah AnnChief Legal OfficerJun 06 '24Sale80.408,000643,21333,300Jun 07 04:44 PM
Shair MatthewDirectorMay 28 '24Sale67.222,000134,438234,522May 29 04:43 PM
Conley EmilyDirectorMay 15 '24Option Exercise12.315,00061,5655,008May 17 04:41 PM
Conley EmilyDirectorMay 15 '24Sale69.095,000345,4508May 17 04:41 PM
Shair MatthewDirectorMay 13 '24Sale65.8437,5002,468,8661,424,698May 15 04:54 PM
Shair MatthewDirectorMay 06 '24Sale69.4837,5002,605,5251,462,198May 08 04:51 PM
Miller Deborah AnnChief Legal OfficerMay 02 '24Option Exercise6.893,00020,67036,300May 03 04:47 PM
Miller Deborah AnnChief Legal OfficerMay 02 '24Sale72.073,000216,20333,300May 03 04:47 PM
Shair MatthewDirectorApr 29 '24Sale67.5137,5002,531,5371,499,698May 01 04:41 PM
Shair MatthewDirectorApr 29 '24Sale67.512,000135,018236,522May 01 04:41 PM
Shair MatthewDirectorApr 22 '24Sale63.6537,5002,386,9101,537,198Apr 24 04:44 PM
Shair MatthewDirectorApr 15 '24Sale65.5637,5002,458,3351,574,698Apr 17 04:46 PM
Conley EmilyDirectorApr 15 '24Option Exercise9.365,00046,8005,008Apr 17 04:44 PM
Conley EmilyDirectorApr 15 '24Sale65.525,000327,6078Apr 17 04:44 PM
Shair MatthewDirectorApr 08 '24Sale68.4437,5002,566,4791,612,198Apr 10 04:45 PM
Miller Deborah AnnChief Legal OfficerApr 04 '24Option Exercise6.893,00020,67036,300Apr 05 04:47 PM
Miller Deborah AnnChief Legal OfficerApr 04 '24Sale73.603,000220,78733,300Apr 05 04:47 PM
Shair MatthewDirectorApr 01 '24Sale76.9237,5002,884,3371,649,698Apr 03 04:45 PM
Hack Andrew A. F.DirectorMar 27 '24Sale72.77880,00064,035,9592,697,267Mar 29 05:15 PM
Miller Deborah AnnChief Legal OfficerMar 28 '24Option Exercise22.5822,000496,74055,300Mar 29 04:46 PM
Miller Deborah AnnChief Legal OfficerMar 28 '24Sale75.2022,0001,654,31133,300Mar 29 04:46 PM
Shair MatthewDirectorMar 25 '24Sale76.7737,5002,878,9821,687,198Mar 27 04:55 PM
Shair MatthewDirectorMar 25 '24Sale76.772,000153,546238,522Mar 27 04:55 PM
Noci DarleneChief Development OfficerMar 22 '24Option Exercise7.7420,000154,80053,300Mar 25 04:49 PM
Noci DarleneChief Development OfficerMar 22 '24Sale77.5120,0001,550,22933,300Mar 25 04:49 PM
Conley EmilyDirectorMar 15 '24Option Exercise9.3613,333124,79713,341Mar 19 04:46 PM
Conley EmilyDirectorMar 15 '24Sale80.9213,3331,078,8838Mar 19 04:46 PM
Shair MatthewDirectorDec 26 '23Sale75.1269,6025,228,3461,774,246Dec 28 05:09 PM
Shair MatthewDirectorDec 28 '23Sale75.4648,5483,663,4921,724,698Dec 28 05:09 PM
Shair MatthewDirectorDec 27 '23Sale75.171,00075,1701,773,246Dec 28 05:09 PM
Protopapas AnnaDirectorDec 18 '23Option Exercise9.365,00046,8005,000Dec 20 04:58 PM
Protopapas AnnaDirectorDec 18 '23Sale75.675,000378,3500Dec 20 04:58 PM
Noci DarleneChief Development OfficerDec 18 '23Option Exercise4.7040,000188,13940,000Dec 20 04:56 PM
Noci DarleneChief Development OfficerDec 18 '23Sale75.8240,0003,032,8000Dec 20 04:56 PM
Miller Deborah AnnChief Legal OfficerDec 18 '23Option Exercise27.8533,046920,33133,046Dec 20 04:54 PM
Miller Deborah AnnChief Legal OfficerDec 19 '23Option Exercise18.935,00094,6505,000Dec 20 04:54 PM
Miller Deborah AnnChief Legal OfficerDec 18 '23Sale75.8233,0462,505,5480Dec 20 04:54 PM
Miller Deborah AnnChief Legal OfficerDec 19 '23Sale75.005,000375,0000Dec 20 04:54 PM
Balcom AlexandraChief Financial OfficerDec 18 '23Option Exercise1.0830,00032,40030,000Dec 20 04:51 PM
Balcom AlexandraChief Financial OfficerDec 18 '23Sale75.8230,0002,274,6000Dec 20 04:51 PM
Shair MatthewDirectorNov 28 '23Sale61.899,150566,3031,843,848Nov 30 04:47 PM